SILODOSIN

SILODOSIN was reported 4101 times

SILODOSIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HOMONYMOUS DIPLOPIA 4 1.0000
1 SYNDESMOPHYTE 4 0.1250
2 ANTI-ANDROGEN WITHDRAWAL SYNDROME 2 0.0952
3 AEROCOCCUS URINAE INFECTION 2 0.0952
4 LACK OF CONCOMITANT DRUG EFFECT 5 0.0877
5 HYPOPARATHYROIDISM SECONDARY 8 0.0690
6 NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC 3 0.0556
7 CEREBELLAR ISCHAEMIA 10 0.0538
8 CRANIAL NERVE INJURY 5 0.0515
9 BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT 4 0.0392
10 OXIDATIVE STRESS 3 0.0319
11 PARAPSORIASIS 7 0.0260
12 TROPONIN ABNORMAL 3 0.0244
13 OEDEMA DUE TO CARDIAC DISEASE 3 0.0214
14 HYPOPARATHYROIDISM 14 0.0183
15 BLOOD TRIGLYCERIDES DECREASED 6 0.0178
16 LEFT ATRIAL DILATATION 21 0.0165
17 VOLVULUS OF SMALL BOWEL 3 0.0152
18 FAECAL VOMITING 8 0.0150
19 SALIVARY GLAND DISORDER 7 0.0149
20 FLOPPY IRIS SYNDROME 5 0.0136
21 SICK LEAVE 3 0.0133
22 BLADDER TAMPONADE 4 0.0132
23 URETHRAL STENOSIS 9 0.0132
24 ABSCESS SOFT TISSUE 2 0.0130
25 ENDOTHELIAL DYSFUNCTION 3 0.0129
26 RETROGRADE EJACULATION 10 0.0126
27 VARICOSE VEIN RUPTURED 4 0.0125
28 WRONG PATIENT 6 0.0120
29 LYMPHOCYTIC HYPOPHYSITIS 3 0.0109
30 AEROMONAS INFECTION 2 0.0106
31 MUCOSAL DRYNESS 21 0.0104
32 PARANEOPLASTIC SYNDROME 7 0.0104
33 HYPOURICAEMIA 3 0.0103
34 CARDIAC FUNCTION TEST ABNORMAL 3 0.0101
35 REVERSIBLE AIRWAYS OBSTRUCTION 5 0.0098
36 PERINEAL PAIN 7 0.0098
37 HAEMATOCRIT INCREASED 22 0.0096
38 OSMOTIC DEMYELINATION SYNDROME 7 0.0095
39 EJACULATION FAILURE 19 0.0095
40 PENILE OEDEMA 3 0.0092
41 ANION GAP DECREASED 3 0.0086
42 MULTIPLE DRUG THERAPY 6 0.0080
43 LIPID METABOLISM DISORDER 3 0.0078
44 LINEAR IGA DISEASE 13 0.0078
45 ADENOCARCINOMA GASTRIC 7 0.0075
46 VOCAL CORD PARALYSIS 13 0.0072
47 RIGHT VENTRICULAR DILATATION 4 0.0069
48 TISSUE INJURY 3 0.0069
49 MITOCHONDRIAL CYTOPATHY 3 0.0068
50 VASCULITIS CEREBRAL 3 0.0067
51 ASPERGILLUS TEST POSITIVE 2 0.0065
52 SUBRETINAL FLUID 7 0.0064
53 BENIGN PROSTATIC HYPERPLASIA 33 0.0064
54 PHYSIOTHERAPY 3 0.0058
55 NEUROENDOCRINE CARCINOMA 4 0.0058
56 ALBUMINURIA 3 0.0056
57 VASCULITIS NECROTISING 4 0.0056
58 BLOOD PH INCREASED 3 0.0054
59 POTENTIATING DRUG INTERACTION 17 0.0051
60 CYSTITIS INTERSTITIAL 8 0.0050
61 HAEMOGLOBIN INCREASED 22 0.0048
62 GIANT CELL ARTERITIS 4 0.0048
63 NASAL CRUSTING 3 0.0046
64 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 8 0.0045
65 MITRAL VALVE STENOSIS 3 0.0045
66 IMMUNE-MEDIATED MYOCARDITIS 7 0.0043
67 ANGLE CLOSURE GLAUCOMA 11 0.0043
68 PRERENAL FAILURE 6 0.0043
69 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
70 BLADDER CATHETERISATION 4 0.0041
71 BRAIN CONTUSION 3 0.0041
72 HAEMORRHAGIC TRANSFORMATION STROKE 6 0.0040
73 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 4 0.0040
74 CYTOMEGALOVIRUS ENTEROCOLITIS 3 0.0039
75 NEPHRITIS 13 0.0039
76 INHIBITORY DRUG INTERACTION 6 0.0038
77 HYPOVOLAEMIA 22 0.0038
78 URINARY RETENTION 125 0.0037
79 METABOLIC ALKALOSIS 6 0.0037
80 BALANOPOSTHITIS 3 0.0036
81 VASCULAR PURPURA 5 0.0036
82 IMMUNE-MEDIATED HYPOTHYROIDISM 4 0.0035
83 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 36 0.0035
84 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 3 0.0034
85 HYPERTONIC BLADDER 9 0.0031
86 AUTONOMIC NEUROPATHY 3 0.0030
87 CALCULUS BLADDER 4 0.0029
88 HYPERURICAEMIA 12 0.0029
89 CAROTID ARTERIOSCLEROSIS 3 0.0029
90 IMMUNE-MEDIATED MYOSITIS 8 0.0029
91 CHRONIC FATIGUE SYNDROME 4 0.0029
92 TUMOUR HAEMORRHAGE 8 0.0028
93 PROSTATOMEGALY 11 0.0028
94 CEREBELLAR SYNDROME 6 0.0027
95 SOFT TISSUE INFECTION 5 0.0027
96 ERECTILE DYSFUNCTION 70 0.0027
97 GENITAL PAIN 4 0.0027
98 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3 0.0027
99 ORTHOSTATIC HYPOTENSION 47 0.0027
100 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 3 0.0027
101 IMPATIENCE 5 0.0027
102 SACROILIITIS 5 0.0026
103 PROSTATITIS 8 0.0026
104 FOLATE DEFICIENCY 3 0.0026
105 BILE DUCT CANCER 3 0.0025
106 HAEMATOMA MUSCLE 3 0.0025
107 CARDIAC DISCOMFORT 5 0.0025
108 CUTANEOUS VASCULITIS 9 0.0025
109 VESTIBULAR DISORDER 3 0.0024
110 HEART VALVE INCOMPETENCE 7 0.0024
111 VACCINATION FAILURE 4 0.0024
112 KLEBSIELLA INFECTION 12 0.0024
113 TYMPANIC MEMBRANE PERFORATION 4 0.0024
114 BLOOD TESTOSTERONE INCREASED 5 0.0023
115 HYPOPITUITARISM 4 0.0023
116 AORTIC VALVE STENOSIS 4 0.0022
117 BLOOD LOSS ANAEMIA 5 0.0022
118 SUBDURAL HAEMORRHAGE 6 0.0022
119 SOPOR 29 0.0022
120 INFUSION SITE RASH 3 0.0022
121 ON AND OFF PHENOMENON 12 0.0022
122 BLOOD CHOLESTEROL DECREASED 4 0.0021
123 BRONCHIAL OBSTRUCTION 3 0.0021
124 PROSTATIC SPECIFIC ANTIGEN INCREASED 29 0.0021
125 CEREBRAL HAEMATOMA 7 0.0021
126 STAPHYLOCOCCAL BACTERAEMIA 9 0.0021
127 BRADYKINESIA 12 0.0020
128 MYASTHENIA GRAVIS CRISIS 3 0.0020
129 HEPATITIS CHOLESTATIC 12 0.0020
130 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
131 URINARY TRACT INFECTION BACTERIAL 5 0.0020
132 IMMUNE-MEDIATED ADVERSE REACTION 3 0.0020
133 TORSADE DE POINTES 15 0.0019
134 IMMUNE-MEDIATED ENTEROCOLITIS 7 0.0019
135 NEUROGENIC BLADDER 4 0.0019
136 HYPERPYREXIA 8 0.0019
137 POLYMYALGIA RHEUMATICA 6 0.0019
138 TORTICOLLIS 4 0.0019
139 CARDIAC FAILURE CHRONIC 8 0.0019
140 PEMPHIGOID 14 0.0019
141 DIVERTICULUM INTESTINAL 8 0.0018
142 PARESIS 4 0.0018
143 HYPOMAGNESAEMIA 25 0.0018
144 ATRIOVENTRICULAR BLOCK COMPLETE 12 0.0018
145 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
146 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
147 EJACULATION DISORDER 5 0.0018
148 ARTERIAL HAEMORRHAGE 2 0.0017
149 PYELONEPHRITIS 15 0.0017
150 GENERALISED OEDEMA 21 0.0017
151 MITRAL VALVE DISEASE 3 0.0017
152 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 4 0.0017
153 PNEUMONIA ASPIRATION 42 0.0017
154 SINUS NODE DYSFUNCTION 3 0.0016
155 PNEUMONIA BACTERIAL 15 0.0016
156 RECTAL CANCER 5 0.0016
157 OLIGURIA 10 0.0016
158 ADENOCARCINOMA OF COLON 3 0.0016
159 INTERVERTEBRAL DISCITIS 3 0.0016
160 HYPOPROTEINAEMIA 3 0.0016
161 HAEMATURIA 54 0.0016
162 RETINAL OEDEMA 3 0.0016
163 URINARY TRACT DISORDER 7 0.0016
164 INTERSTITIAL LUNG DISEASE 75 0.0015
165 DELUSION 24 0.0015
166 HYPOCALCAEMIA 29 0.0015
167 HYPERSENSITIVITY VASCULITIS 4 0.0015
168 DYSURIA 56 0.0015
169 DERMATITIS BULLOUS 11 0.0015
170 FAECES SOFT 11 0.0015
171 HIGH DENSITY LIPOPROTEIN DECREASED 5 0.0015
172 HEPATIC ENCEPHALOPATHY 14 0.0015
173 SQUAMOUS CELL CARCINOMA OF SKIN 9 0.0015
174 COLITIS MICROSCOPIC 7 0.0015
175 IMMUNE-MEDIATED HEPATITIS 3 0.0015
176 HEPATIC FIBROSIS 5 0.0015
177 PUSTULAR PSORIASIS 5 0.0015
178 POLYCYTHAEMIA 3 0.0015
179 CHOLANGITIS 9 0.0015
180 MICROCYTIC ANAEMIA 3 0.0014
181 PSYCHOMOTOR RETARDATION 4 0.0014
182 CYTOKINE RELEASE SYNDROME 28 0.0014
183 HYPERPHOSPHATAEMIA 3 0.0014
184 CEREBRAL INFARCTION 34 0.0014
185 INFUSION SITE BRUISING 3 0.0014
186 PHYSICAL DISABILITY 6 0.0014
187 PRESYNCOPE 33 0.0014
188 CARDIAC FAILURE ACUTE 9 0.0013
189 PSEUDOMEMBRANOUS COLITIS 3 0.0013
190 INFUSION SITE REACTION 4 0.0013
191 CORNEAL OEDEMA 3 0.0013
192 MENINGITIS ASEPTIC 6 0.0013
193 HYDRONEPHROSIS 10 0.0013
194 METABOLIC ENCEPHALOPATHY 4 0.0013
195 GENERAL PHYSICAL CONDITION ABNORMAL 9 0.0013
196 NOCTURIA 16 0.0013
197 LARGE INTESTINE POLYP 9 0.0013
198 DIASTOLIC DYSFUNCTION 4 0.0013
199 INFUSION SITE INFECTION 3 0.0013
200 HYPOKALAEMIA 59 0.0013
201 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
202 URINARY HESITATION 3 0.0013
203 URINE FLOW DECREASED 3 0.0013
204 AZOTAEMIA 5 0.0013
205 OBSTRUCTION 5 0.0013
206 LONG QT SYNDROME 3 0.0013
207 HUMERUS FRACTURE 6 0.0012
208 SKIN EROSION 4 0.0012
209 DIZZINESS POSTURAL 12 0.0012
210 HEPATITIS ACUTE 8 0.0012
211 SHOCK HAEMORRHAGIC 10 0.0012
212 MICTURITION URGENCY 14 0.0012
213 PULMONARY CONGESTION 16 0.0012
214 PENIS DISORDER 3 0.0012
215 CORONAVIRUS INFECTION 8 0.0012
216 PERSECUTORY DELUSION 3 0.0012
217 PROSTATE CANCER METASTATIC 4 0.0012
218 VENTRICULAR HYPERTROPHY 3 0.0012
219 PLATELET DISORDER 3 0.0012
220 COVID-19 PNEUMONIA 14 0.0012
221 HYPONATRAEMIA 66 0.0012
222 INTERVERTEBRAL DISC DISORDER 5 0.0012
223 HYPERTENSIVE CRISIS 13 0.0012
224 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
225 PSYCHOMOTOR SKILLS IMPAIRED 3 0.0011
226 DUODENAL ULCER 8 0.0011
227 AGRANULOCYTOSIS 21 0.0011
228 ATRIAL FLUTTER 9 0.0011
229 ILEUS 14 0.0011
230 RASH MACULO-PAPULAR 25 0.0011
231 CONJUNCTIVAL HYPERAEMIA 4 0.0011
232 EAR CONGESTION 3 0.0011
233 ANORGASMIA 3 0.0011
234 HEPATIC CYTOLYSIS 14 0.0011
235 VENTRICULAR ARRHYTHMIA 4 0.0011
236 PROCTALGIA 7 0.0011
237 ACUTE CORONARY SYNDROME 9 0.0011
238 SECOND PRIMARY MALIGNANCY 9 0.0011
239 FREEZING PHENOMENON 4 0.0011
240 TENDON DISORDER 7 0.0011
241 HYPERBILIRUBINAEMIA 11 0.0011
242 ACIDOSIS 8 0.0010
243 HERPES VIRUS INFECTION 6 0.0010
244 HYPOALBUMINAEMIA 8 0.0010
245 ABDOMINAL WALL HAEMATOMA 2 0.0010
246 HAEMORRHAGIC STROKE 8 0.0010
247 HEPATIC FUNCTION ABNORMAL 38 0.0010
248 THORACIC VERTEBRAL FRACTURE 3 0.0010
249 ARRHYTHMIA 48 0.0010
250 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
251 IDIOPATHIC PULMONARY FIBROSIS 4 0.0010
252 OESOPHAGEAL CANDIDIASIS 4 0.0010
253 BRADYCARDIA 53 0.0010
254 LUNG ADENOCARCINOMA 3 0.0010
255 MYELOFIBROSIS 3 0.0010
256 PULMONARY TOXICITY 7 0.0010
257 ORAL CANDIDIASIS 13 0.0010
258 ACUTE KIDNEY INJURY 150 0.0010
259 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
260 ESCHERICHIA INFECTION 8 0.0010
261 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
262 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
263 SPINAL STENOSIS 4 0.0010
264 TESTICULAR PAIN 3 0.0009
265 BILE DUCT STONE 3 0.0009
266 LYMPHOPENIA 13 0.0009
267 HYPERKALAEMIA 32 0.0009
268 SUBDURAL HAEMATOMA 13 0.0009
269 DEAFNESS UNILATERAL 5 0.0009
270 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
271 ILEUS PARALYTIC 4 0.0009
272 ADENOCARCINOMA 2 0.0009
273 ANGIOPATHY 5 0.0009
274 VASCULAR DEVICE INFECTION 4 0.0009
275 URINE ABNORMALITY 4 0.0009
276 EXOSTOSIS 8 0.0009
277 MIOSIS 7 0.0009
278 LEFT VENTRICULAR FAILURE 3 0.0009
279 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
280 PRIAPISM 3 0.0009
281 ENCEPHALITIS 6 0.0009
282 NEPHROGENIC ANAEMIA 4 0.0009
283 HYPERTRANSAMINASAEMIA 6 0.0009
284 AORTIC STENOSIS 3 0.0009
285 HALLUCINATION, VISUAL 18 0.0009
286 TYPE I HYPERSENSITIVITY 3 0.0009
287 BRONCHIOLITIS 3 0.0009
288 NECROTISING FASCIITIS 3 0.0009
289 JAUNDICE CHOLESTATIC 3 0.0008
290 PROSTATE CANCER STAGE IV 3 0.0008
291 GLOSSITIS 3 0.0008
292 POISONING DELIBERATE 8 0.0008
293 SKIN DISORDER 28 0.0008
294 RHABDOMYOLYSIS 35 0.0008
295 MYOCLONUS 10 0.0008
296 NON-SMALL CELL LUNG CANCER 4 0.0008
297 FACIAL BONES FRACTURE 3 0.0008
298 DRUG-INDUCED LIVER INJURY 26 0.0008
299 ASPIRATION 9 0.0008
300 PARKINSONISM 8 0.0008
301 MELAENA 18 0.0008
302 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 2 0.0008
303 PROTEIN TOTAL DECREASED 3 0.0008
304 PURPURA 7 0.0008
305 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
306 NEUTROPHIL COUNT DECREASED 32 0.0008
307 ATRIAL FIBRILLATION 74 0.0008
308 DRUG INTERACTION 120 0.0008
309 PRODUCT PRESCRIBING ERROR 18 0.0008
310 CATARACT 45 0.0008
311 RENAL CYST 6 0.0008
312 CONJUNCTIVITIS 14 0.0008
313 METABOLIC ACIDOSIS 24 0.0007
314 SYNCOPE 75 0.0007
315 COMPRESSION FRACTURE 4 0.0007
316 DYSPNOEA EXERTIONAL 28 0.0007
317 HYPOGLYCAEMIA 36 0.0007
318 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
319 PERIPHERAL ISCHAEMIA 3 0.0007
320 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
321 ARTHRITIS BACTERIAL 3 0.0007
322 HICCUPS 6 0.0007
323 BLOOD TESTOSTERONE DECREASED 5 0.0007
324 HOT FLUSH 55 0.0007
325 ISCHAEMIC STROKE 13 0.0007
326 VENTRICULAR TACHYCARDIA 12 0.0007
327 SPINAL COMPRESSION FRACTURE 6 0.0007
328 PROSTATIC DISORDER 4 0.0007
329 ATELECTASIS 7 0.0007
330 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
331 SINUS BRADYCARDIA 7 0.0007
332 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
333 GASTRIC ULCER HAEMORRHAGE 4 0.0007
334 HEMIPLEGIA 6 0.0007
335 LARGE INTESTINE PERFORATION 5 0.0007
336 POLLAKIURIA 30 0.0007
337 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
338 BODY TEMPERATURE DECREASED 7 0.0007
339 LIP OEDEMA 3 0.0007
340 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
341 CHOLECYSTITIS ACUTE 4 0.0007
342 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
343 HYPERTONIA 4 0.0007
344 ELECTROCARDIOGRAM QT PROLONGED 25 0.0007
345 PNEUMOTHORAX 11 0.0007
346 ENTEROCOLITIS 4 0.0007
347 BLOOD URIC ACID INCREASED 4 0.0007
348 IMMOBILE 3 0.0007
349 PULMONARY FUNCTION TEST DECREASED 3 0.0007
350 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
351 HAEMOPTYSIS 19 0.0007
352 BLOOD PRESSURE DECREASED 45 0.0007
353 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
354 ACUTE RESPIRATORY FAILURE 13 0.0007
355 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
356 RHINITIS ALLERGIC 3 0.0007
357 PLEURISY 4 0.0007
358 COLON CANCER 10 0.0007
359 TRANSFUSION 7 0.0007
360 ANAEMIA 127 0.0007
361 DRUG LEVEL INCREASED 11 0.0007
362 INGUINAL HERNIA 4 0.0007
363 TROPONIN INCREASED 5 0.0007
364 IRON DEFICIENCY ANAEMIA 6 0.0006
365 LACTIC ACIDOSIS 21 0.0006
366 HYPOTENSION 130 0.0006
367 RENAL FUNCTION TEST ABNORMAL 3 0.0006
368 CIRCULATORY COLLAPSE 11 0.0006
369 PANCYTOPENIA 36 0.0006
370 SKIN LACERATION 7 0.0006
371 ERYTHEMA MULTIFORME 6 0.0006
372 CARDIAC FAILURE 51 0.0006
373 DELIRIUM 22 0.0006
374 FEBRILE NEUTROPENIA 42 0.0006
375 CARDIAC TAMPONADE 3 0.0006
376 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
377 PLEURAL EFFUSION 38 0.0006
378 HAEMOGLOBIN ABNORMAL 4 0.0006
379 HYPERTHYROIDISM 9 0.0006
380 RASH VESICULAR 3 0.0006
381 MYASTHENIA GRAVIS 5 0.0006
382 THROMBOTIC MICROANGIOPATHY 6 0.0006
383 RENAL CELL CARCINOMA 3 0.0006
384 SHOCK 14 0.0006
385 GASTRIC HAEMORRHAGE 7 0.0006
386 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
387 PULMONARY MASS 9 0.0006
388 RASH MACULAR 21 0.0006
389 BLOOD CREATININE INCREASED 39 0.0006
390 ERYSIPELAS 3 0.0006
391 EMPHYSEMA 6 0.0006
392 INFUSION SITE ERYTHEMA 5 0.0006
393 FACE OEDEMA 10 0.0006
394 PATHOLOGICAL FRACTURE 3 0.0006
395 FEMORAL NECK FRACTURE 3 0.0006
396 ENDOCARDITIS 3 0.0006
397 NEPHROTIC SYNDROME 4 0.0006
398 ANAPHYLACTIC SHOCK 15 0.0006
399 APLASIA PURE RED CELL 2 0.0006
400 PROTEINURIA 11 0.0006
401 SEPTIC SHOCK 25 0.0006
402 URINARY INCONTINENCE 17 0.0006
403 CHOLESTASIS 11 0.0006
404 URINE OUTPUT DECREASED 5 0.0006
405 ENCEPHALOPATHY 14 0.0006
406 POLYARTHRITIS 3 0.0006
407 CARDIOMEGALY 7 0.0006
408 SERUM FERRITIN INCREASED 3 0.0006
409 DEVICE OCCLUSION 8 0.0006
410 TUMOUR LYSIS SYNDROME 5 0.0006
411 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
412 LUNG INFILTRATION 5 0.0006
413 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
414 CEREBRAL HAEMORRHAGE 20 0.0006
415 MYOSITIS 5 0.0006
416 COGNITIVE DISORDER 26 0.0006
417 BEHAVIOUR DISORDER 3 0.0006
418 NONSPECIFIC REACTION 3 0.0005
419 COMA 26 0.0005
420 CHOKING SENSATION 3 0.0005
421 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
422 RENAL IMPAIRMENT 45 0.0005
423 MACULAR OEDEMA 3 0.0005
424 PANCREATITIS ACUTE 12 0.0005
425 ARTERIOSCLEROSIS 5 0.0005
426 SARS-COV-2 TEST POSITIVE 7 0.0005
427 DISORIENTATION 21 0.0005
428 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
429 GASTRIC ULCER 10 0.0005
430 AORTIC ANEURYSM 4 0.0005
431 PRODUCTIVE COUGH 25 0.0005
432 EXERCISE TOLERANCE DECREASED 3 0.0005
433 METABOLIC DISORDER 3 0.0005
434 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
435 TACHYPNOEA 7 0.0005
436 EOSINOPHILIA 9 0.0005
437 ACUTE MYELOID LEUKAEMIA 8 0.0005
438 CONFUSIONAL STATE 82 0.0005
439 CATARACT OPERATION 3 0.0005
440 CHOLECYSTITIS 6 0.0005
441 BLADDER DISORDER 5 0.0005
442 CARDIAC PACEMAKER INSERTION 3 0.0005
443 TYPE 1 DIABETES MELLITUS 3 0.0005
444 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
445 GANGRENE 3 0.0005
446 PLATELET COUNT DECREASED 53 0.0005
447 TOXIC SKIN ERUPTION 5 0.0005
448 THROMBOCYTOPENIA 55 0.0005
449 SUBARACHNOID HAEMORRHAGE 5 0.0005
450 POLYURIA 4 0.0005
451 EAR DISCOMFORT 5 0.0005
452 IMPAIRED QUALITY OF LIFE 7 0.0005
453 AORTIC DISSECTION 2 0.0005
454 VENTRICULAR EXTRASYSTOLES 5 0.0005
455 PULMONARY HYPERTENSION 10 0.0005
456 EOSINOPHIL COUNT INCREASED 4 0.0005
457 GASTROENTERITIS 7 0.0005
458 NASAL DRYNESS 3 0.0005
459 DYSARTHRIA 18 0.0005
460 WEIGHT FLUCTUATION 5 0.0005
461 ASCITES 14 0.0005
462 VERTIGO 29 0.0005
463 INCONTINENCE 5 0.0005
464 AORTIC VALVE INCOMPETENCE 2 0.0005
465 HYPOTHYROIDISM 15 0.0005
466 URINARY TRACT INFECTION 80 0.0005
467 DYSKINESIA 19 0.0005
468 PSEUDOMONAS INFECTION 4 0.0005
469 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 12 0.0005
470 DEHYDRATION 62 0.0005
471 OEDEMA 25 0.0005
472 BRADYPHRENIA 3 0.0005
473 WOUND INFECTION 5 0.0005
474 DYSPHAGIA 43 0.0005
475 OEDEMA PERIPHERAL 55 0.0005
476 STEVENS-JOHNSON SYNDROME 10 0.0004
477 JOINT RANGE OF MOTION DECREASED 6 0.0004
478 OCULAR DISCOMFORT 5 0.0004
479 LOSS OF LIBIDO 4 0.0004
480 METASTASES TO LYMPH NODES 3 0.0004
481 BLOOD BILIRUBIN INCREASED 12 0.0004
482 PNEUMONITIS 12 0.0004
483 HYPERGLYCAEMIA 16 0.0004
484 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
485 PERIPHERAL COLDNESS 6 0.0004
486 MYOCARDITIS 5 0.0004
487 DECREASED APPETITE 101 0.0004
488 UROSEPSIS 4 0.0004
489 DIVERTICULITIS 12 0.0004
490 METASTASES TO LUNG 5 0.0004
491 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
492 ELECTROLYTE IMBALANCE 5 0.0004
493 HYPOPHAGIA 11 0.0004
494 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 10 0.0004
495 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
496 MANIA 7 0.0004
497 EPILEPSY 13 0.0004
498 GENERAL PHYSICAL HEALTH DETERIORATION 49 0.0004
499 HAND FRACTURE 3 0.0004
500 FRACTURE 8 0.0004
501 SPUTUM DISCOLOURED 4 0.0004
502 BACTERAEMIA 5 0.0004
503 NEUTROPENIA 57 0.0004
504 HYPERSOMNIA 12 0.0004
505 MUSCLE RIGIDITY 5 0.0004
506 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
507 ADRENAL INSUFFICIENCY 5 0.0004
508 APATHY 6 0.0004
509 HALLUCINATION 31 0.0004
510 MAJOR DEPRESSION 3 0.0004
511 CYTOPENIA 5 0.0004
512 RENAL DISORDER 19 0.0004
513 HEART RATE DECREASED 14 0.0004
514 METASTASES TO LIVER 7 0.0004
515 INTESTINAL OBSTRUCTION 15 0.0004
516 DRUG LEVEL DECREASED 4 0.0004
517 LIPASE INCREASED 3 0.0004
518 NASAL CONGESTION 23 0.0004
519 VISUAL ACUITY REDUCED 13 0.0004
520 ATRIOVENTRICULAR BLOCK 3 0.0004
521 LUNG DISORDER 19 0.0004
522 POOR VENOUS ACCESS 4 0.0004
523 CONSTIPATION 84 0.0004
524 NERVOUS SYSTEM DISORDER 12 0.0004
525 RESPIRATORY FAILURE 28 0.0004
526 APLASTIC ANAEMIA 2 0.0004
527 SEDATION 10 0.0004
528 CYANOSIS 6 0.0004
529 PRODUCT USE COMPLAINT 6 0.0004
530 ANKYLOSING SPONDYLITIS 5 0.0004
531 SCRATCH 4 0.0004
532 FURUNCLE 3 0.0004
533 DYSSTASIA 11 0.0004
534 ABSCESS 6 0.0004
535 HEPATIC STEATOSIS 7 0.0004
536 BACTERIAL INFECTION 7 0.0004
537 ANAL FISTULA 2 0.0004
538 TRANSPLANT REJECTION 3 0.0004
539 BLOOD DISORDER 3 0.0004
540 EPISTAXIS 28 0.0004
541 ACUTE MYOCARDIAL INFARCTION 11 0.0004
542 SEIZURE 43 0.0004
543 ASPHYXIA 3 0.0004
544 LOSS OF CONSCIOUSNESS 47 0.0004
545 FALL 122 0.0004
546 ACUTE HEPATIC FAILURE 5 0.0004
547 METASTASES TO BONE 6 0.0004
548 PYREXIA 126 0.0004
549 STOMATITIS 22 0.0004
550 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
551 RESPIRATORY DISTRESS 10 0.0004
552 ASTHENIA 136 0.0004
553 ANGIOEDEMA 16 0.0004
554 CYTOMEGALOVIRUS INFECTION 6 0.0004
555 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
556 LIVER DISORDER 16 0.0004
557 HAEMORRHOIDS 7 0.0004
558 CHOKING 7 0.0004
559 BALANCE DISORDER 31 0.0004
560 DEMENTIA 10 0.0004
561 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
562 CELLULITIS 18 0.0004
563 NEPHROPATHY TOXIC 4 0.0004
564 ACNE 27 0.0004
565 GASTRIC CANCER 9 0.0004
566 HEART RATE IRREGULAR 8 0.0004
567 HAEMATOCRIT DECREASED 7 0.0004
568 HEPATOCELLULAR INJURY 5 0.0004
569 VITAMIN D DECREASED 3 0.0004
570 PRESCRIBED UNDERDOSE 7 0.0004
571 RED BLOOD CELL COUNT DECREASED 10 0.0003
572 RECTAL HAEMORRHAGE 15 0.0003
573 ANGINA PECTORIS 10 0.0003
574 ANURIA 3 0.0003
575 HAEMATOMA 9 0.0003
576 MYELODYSPLASTIC SYNDROME 5 0.0003
577 TASTE DISORDER 7 0.0003
578 GROIN PAIN 3 0.0003
579 SEXUAL DYSFUNCTION 4 0.0003
580 SEPSIS 38 0.0003
581 LUNG NEOPLASM MALIGNANT 14 0.0003
582 LYMPHOCYTE COUNT DECREASED 6 0.0003
583 RESPIRATORY RATE INCREASED 3 0.0003
584 ATAXIA 4 0.0003
585 HAEMOLYTIC ANAEMIA 3 0.0003
586 ANAL INCONTINENCE 3 0.0003
587 OROPHARYNGEAL DISCOMFORT 3 0.0003
588 MALIGNANT NEOPLASM PROGRESSION 34 0.0003
589 C-REACTIVE PROTEIN INCREASED 12 0.0003
590 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
591 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
592 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
593 HYPERCALCAEMIA 4 0.0003
594 MIDDLE INSOMNIA 6 0.0003
595 THERAPY PARTIAL RESPONDER 5 0.0003
596 OXYGEN SATURATION DECREASED 18 0.0003
597 PEMPHIGUS 4 0.0003
598 BRAIN FOG 5 0.0003
599 SQUAMOUS CELL CARCINOMA 3 0.0003
600 ABDOMINAL PAIN LOWER 8 0.0003
601 HYPERTENSION 67 0.0003
602 BLOOD URINE PRESENT 6 0.0003
603 MUSCLE ATROPHY 4 0.0003
604 HALLUCINATION, AUDITORY 5 0.0003
605 CYSTITIS 10 0.0003
606 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
607 POST PROCEDURAL COMPLICATION 6 0.0003
608 HYPOXIA 11 0.0003
609 SEROTONIN SYNDROME 6 0.0003
610 WEIGHT DECREASED 87 0.0003
611 GLAUCOMA 6 0.0003
612 CARDIO-RESPIRATORY ARREST 13 0.0003
613 PNEUMONIA 100 0.0003
614 MUSCULOSKELETAL STIFFNESS 27 0.0003
615 DIPLOPIA 8 0.0003
616 COVID-19 54 0.0003
617 AUTOIMMUNE DISORDER 3 0.0003
618 ANGINA UNSTABLE 2 0.0003
619 ECZEMA 16 0.0003
620 MYELOSUPPRESSION 11 0.0003
621 PERICARDIAL EFFUSION 7 0.0003
622 APPETITE DISORDER 2 0.0003
623 HYPOTONIA 3 0.0003
624 GAIT INABILITY 10 0.0003
625 DIZZINESS 149 0.0003
626 BLOOD UREA INCREASED 5 0.0003
627 APHASIA 9 0.0003
628 SLEEP DISORDER 21 0.0003
629 PRODUCT ADMINISTRATION ERROR 6 0.0003
630 DISTURBANCE IN ATTENTION 16 0.0003
631 EYELID PTOSIS 3 0.0003
632 DRY THROAT 3 0.0003
633 TOOTH ABSCESS 3 0.0003
634 MOTOR DYSFUNCTION 3 0.0003
635 RENAL FAILURE 39 0.0003
636 SOMNOLENCE 59 0.0003
637 EUPHORIC MOOD 3 0.0003
638 RIB FRACTURE 6 0.0003
639 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
640 TENDERNESS 3 0.0003
641 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
642 AGITATION 21 0.0003
643 SUDDEN DEATH 3 0.0003
644 SEASONAL ALLERGY 4 0.0003
645 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 20 0.0003
646 SUICIDE ATTEMPT 17 0.0003
647 THIRST 5 0.0003
648 GOUT 5 0.0003
649 LEUKOCYTOSIS 5 0.0003
650 HYPOKINESIA 4 0.0003
651 ACCIDENTAL OVERDOSE 10 0.0003
652 TOOTH FRACTURE 3 0.0003
653 UNRESPONSIVE TO STIMULI 7 0.0003
654 TACHYCARDIA 24 0.0003
655 VENTRICULAR FIBRILLATION 3 0.0003
656 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
657 ARTHROPOD BITE 2 0.0003
658 TRANSAMINASES INCREASED 6 0.0003
659 MALNUTRITION 3 0.0003
660 HAEMORRHAGE INTRACRANIAL 4 0.0003
661 SKIN INFECTION 3 0.0003
662 MUCOSAL INFLAMMATION 7 0.0003
663 BLOOD CALCIUM DECREASED 3 0.0003
664 BLOOD SODIUM DECREASED 5 0.0003
665 MITRAL VALVE INCOMPETENCE 3 0.0003
666 MOBILITY DECREASED 19 0.0003
667 MYOCARDIAL ISCHAEMIA 3 0.0003
668 DIARRHOEA 170 0.0003
669 CHRONIC KIDNEY DISEASE 20 0.0003
670 DERMATITIS CONTACT 3 0.0003
671 DEEP VEIN THROMBOSIS 17 0.0003
672 PROSTATE CANCER 21 0.0003
673 DRY MOUTH 21 0.0003
674 ANKLE FRACTURE 4 0.0003
675 APHTHOUS ULCER 2 0.0003
676 VASCULITIS 3 0.0003
677 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
678 EJECTION FRACTION DECREASED 4 0.0003
679 SPINAL PAIN 3 0.0003
680 BLOOD PRESSURE INCREASED 39 0.0003
681 HEAD INJURY 8 0.0003
682 BLOOD PRESSURE ABNORMAL 5 0.0003
683 POLYNEUROPATHY 3 0.0003
684 INTENTIONAL OVERDOSE 16 0.0002
685 HEPATIC ENZYME INCREASED 17 0.0002
686 FLATULENCE 14 0.0002
687 MUSCULAR WEAKNESS 28 0.0002
688 BLOOD POTASSIUM INCREASED 4 0.0002
689 DISCOMFORT 15 0.0002
690 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
691 THERAPY NON-RESPONDER 11 0.0002
692 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
693 HERPES ZOSTER 14 0.0002
694 TENDON RUPTURE 3 0.0002
695 CYST 3 0.0002
696 EXTRAPYRAMIDAL DISORDER 6 0.0002
697 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
698 INTENTIONAL PRODUCT MISUSE 21 0.0002
699 PRODUCT USE ISSUE 45 0.0002
700 WITHDRAWAL SYNDROME 10 0.0002
701 ABDOMINAL PAIN UPPER 49 0.0002
702 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
703 BLADDER CANCER 14 0.0002
704 GAIT DISTURBANCE 45 0.0002
705 SCAR 4 0.0002
706 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
707 MUSCULOSKELETAL DISCOMFORT 4 0.0002
708 PARANOIA 4 0.0002
709 HIATUS HERNIA 3 0.0002
710 FAECES DISCOLOURED 5 0.0002
711 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
712 HAEMORRHAGE 24 0.0002
713 BEDRIDDEN 3 0.0002
714 DRUG ABUSE 19 0.0002
715 GASTROINTESTINAL HAEMORRHAGE 19 0.0002
716 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
717 DRUG ERUPTION 4 0.0002
718 HYPERHIDROSIS 29 0.0002
719 BONE DENSITY DECREASED 7 0.0002
720 PRODUCT TASTE ABNORMAL 3 0.0002
721 GASTROENTERITIS VIRAL 4 0.0002
722 OSTEOMYELITIS 4 0.0002
723 CONDITION AGGRAVATED 67 0.0002
724 RESTLESS LEGS SYNDROME 4 0.0002
725 AGGRESSION 11 0.0002
726 DISEASE PROGRESSION 26 0.0002
727 CARDIAC ARREST 18 0.0002
728 HAEMATOCHEZIA 12 0.0002
729 BLOOD GLUCOSE ABNORMAL 4 0.0002
730 FLUID RETENTION 11 0.0002
731 WOUND 6 0.0002
732 HAEMOGLOBIN DECREASED 22 0.0002
733 EYE DISORDER 7 0.0002
734 HEPATIC CIRRHOSIS 4 0.0002
735 BLINDNESS UNILATERAL 3 0.0002
736 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
737 SINUS TACHYCARDIA 3 0.0002
738 PRURITUS 81 0.0002
739 ABDOMINAL DISTENSION 22 0.0002
740 PULMONARY EMBOLISM 20 0.0002
741 INTENTIONAL DOSE OMISSION 6 0.0002
742 NEUROPATHY PERIPHERAL 20 0.0002
743 THERAPY INTERRUPTED 15 0.0002
744 CARDIOGENIC SHOCK 3 0.0002
745 BLOOD PRESSURE FLUCTUATION 5 0.0002
746 LOWER LIMB FRACTURE 4 0.0002
747 FATIGUE 161 0.0002
748 PRESCRIBED OVERDOSE 4 0.0002
749 NEURALGIA 5 0.0002
750 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
751 MALAISE 90 0.0002
752 DYSPHONIA 12 0.0002
753 PLASMA CELL MYELOMA 8 0.0002
754 ORAL HERPES 4 0.0002
755 VISION BLURRED 28 0.0002
756 LABORATORY TEST ABNORMAL 6 0.0002
757 CARDIOMYOPATHY 3 0.0002
758 NEOPLASM PROGRESSION 7 0.0002
759 OFF LABEL USE 175 0.0002
760 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
761 UNEVALUABLE EVENT 15 0.0002
762 DYSPNOEA 112 0.0002
763 NEPHROLITHIASIS 9 0.0002
764 INSURANCE ISSUE 3 0.0002
765 TINNITUS 9 0.0002
766 HIP ARTHROPLASTY 3 0.0002
767 THYROID DISORDER 3 0.0002
768 LYMPHOMA 3 0.0002
769 MUSCULOSKELETAL CHEST PAIN 3 0.0002
770 PERITONITIS 4 0.0002
771 LUNG INFECTION 3 0.0002
772 RESPIRATORY TRACT INFECTION 5 0.0002
773 SPEECH DISORDER 10 0.0002
774 MOUTH ULCERATION 4 0.0002
775 GASTROINTESTINAL DISORDER 17 0.0002
776 ABDOMINAL PAIN 44 0.0002
777 ULCER 3 0.0002
778 SCIATICA 3 0.0002
779 JAUNDICE 5 0.0002
780 POOR QUALITY SLEEP 4 0.0002
781 WHEEZING 11 0.0002
782 MUSCLE TIGHTNESS 3 0.0002
783 BACK PAIN 43 0.0002
784 COLITIS 7 0.0002
785 OROPHARYNGEAL PAIN 17 0.0002
786 PRODUCT PRESCRIBING ISSUE 4 0.0002
787 CHEST PAIN 34 0.0002
788 RASH 80 0.0002
789 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
790 RESPIRATORY ARREST 5 0.0002
791 ABNORMAL DREAMS 5 0.0002
792 HYPOAESTHESIA 27 0.0002
793 ERYTHEMA 37 0.0002
794 URTICARIA 30 0.0002
795 CANDIDA INFECTION 3 0.0002
796 PRODUCT USE IN UNAPPROVED INDICATION 44 0.0002
797 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
798 COUGH 48 0.0002
799 DIABETES MELLITUS 13 0.0002
800 COLD SWEAT 3 0.0002
801 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
802 AMNESIA 11 0.0002
803 MUSCLE SPASMS 31 0.0002
804 RESPIRATORY DISORDER 5 0.0002
805 HEPATIC CANCER 4 0.0002
806 TOOTHACHE 3 0.0002
807 WEIGHT INCREASED 37 0.0002
808 INSOMNIA 44 0.0002
809 END STAGE RENAL DISEASE 3 0.0002
810 UNDERDOSE 12 0.0002
811 HYPOACUSIS 7 0.0002
812 CARDIAC FAILURE CONGESTIVE 13 0.0002
813 OSTEONECROSIS OF JAW 4 0.0002
814 HEART RATE INCREASED 16 0.0002
815 THINKING ABNORMAL 3 0.0002
816 TREMOR 26 0.0002
817 EYE IRRITATION 9 0.0002
818 HEPATITIS 4 0.0002
819 PRODUCT SUBSTITUTION ISSUE 9 0.0002
820 PULMONARY OEDEMA 7 0.0002
821 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
822 PERIPHERAL SWELLING 24 0.0002
823 MOVEMENT DISORDER 5 0.0002
824 HERNIA 3 0.0002
825 INFLAMMATION 8 0.0002
826 SKIN ULCER 4 0.0002
827 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
828 CHILLS 18 0.0002
829 DEAFNESS 4 0.0002
830 MYALGIA 26 0.0002
831 KIDNEY INFECTION 3 0.0002
832 MEMORY IMPAIRMENT 21 0.0002
833 ARTHRITIS 12 0.0002
834 PARAESTHESIA 24 0.0002
835 CHOLELITHIASIS 5 0.0002
836 STAPHYLOCOCCAL INFECTION 5 0.0002
837 ABNORMAL BEHAVIOUR 6 0.0002
838 PANCREATITIS 8 0.0002
839 FULL BLOOD COUNT DECREASED 3 0.0001
840 PRODUCT PHYSICAL ISSUE 3 0.0001
841 FREQUENT BOWEL MOVEMENTS 4 0.0001
842 LIMB INJURY 4 0.0001
843 DISEASE RECURRENCE 7 0.0001
844 BODY TEMPERATURE INCREASED 3 0.0001
845 HEADACHE 92 0.0001
846 CHEST DISCOMFORT 15 0.0001
847 NASOPHARYNGITIS 27 0.0001
848 SKIN LESION 4 0.0001
849 INFECTION 21 0.0001
850 ARTHRALGIA 60 0.0001
851 FEELING COLD 4 0.0001
852 APHONIA 2 0.0001
853 BLISTER 8 0.0001
854 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
855 OSTEOARTHRITIS 6 0.0001
856 LYMPHADENOPATHY 5 0.0001
857 EATING DISORDER 3 0.0001
858 RETCHING 3 0.0001
859 DRY EYE 7 0.0001
860 CARDIAC DISORDER 13 0.0001
861 PANCREATIC CARCINOMA 4 0.0001
862 MYOCARDIAL INFARCTION 24 0.0001
863 VISUAL IMPAIRMENT 17 0.0001
864 ABDOMINAL DISCOMFORT 23 0.0001
865 RESTLESSNESS 5 0.0001
866 BONE PAIN 8 0.0001
867 SURGERY 8 0.0001
868 INFUSION RELATED REACTION 9 0.0001
869 BRONCHITIS 10 0.0001
870 DEATH 116 0.0001
871 INFLUENZA 15 0.0001
872 NERVOUSNESS 7 0.0001
873 THROAT IRRITATION 6 0.0001
874 MUSCULOSKELETAL PAIN 7 0.0001
875 BLOOD POTASSIUM DECREASED 4 0.0001
876 CHROMATURIA 3 0.0001
877 HEPATIC FAILURE 4 0.0001
878 PAIN IN EXTREMITY 39 0.0001
879 DYSPEPSIA 13 0.0001
880 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
881 FEELING HOT 8 0.0001
882 HOSPITALISATION 20 0.0001
883 FEMUR FRACTURE 4 0.0001
884 NAUSEA 102 0.0001
885 FLUSHING 13 0.0001
886 BLOOD GLUCOSE INCREASED 24 0.0001
887 DRY SKIN 17 0.0001
888 NECK PAIN 7 0.0001
889 OVERDOSE 27 0.0001
890 DIABETIC KETOACIDOSIS 3 0.0001
891 CONTUSION 12 0.0001
892 EYE PAIN 7 0.0001
893 CEREBROVASCULAR ACCIDENT 21 0.0001
894 ASTHMA 14 0.0001
895 INCORRECT DOSE ADMINISTERED 28 0.0001
896 ADVERSE DRUG REACTION 11 0.0001
897 LETHARGY 7 0.0001
898 VIRAL INFECTION 4 0.0001
899 LIP SWELLING 4 0.0001
900 LEUKOPENIA 6 0.0001
901 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
902 HAEMATEMESIS 3 0.0001
903 RENAL FAILURE ACUTE 5 0.0001
904 DRUG INEFFECTIVE 154 0.0001
905 JOINT SWELLING 14 0.0001
906 NIGHTMARE 4 0.0001
907 ANHEDONIA 3 0.0001
908 INJURY 8 0.0001
909 HYPERSENSITIVITY 21 0.0001
910 TOXICITY TO VARIOUS AGENTS 19 0.0001
911 PRODUCT DOSE OMISSION ISSUE 33 0.0001
912 PALPITATIONS 13 0.0001
913 THROAT TIGHTNESS 3 0.0001
914 MOOD ALTERED 3 0.0001
915 SKIN DISCOLOURATION 5 0.0001
916 MENTAL STATUS CHANGES 3 0.0001
917 ARTHROPATHY 6 0.0001
918 DYSGEUSIA 8 0.0001
919 BLOOD CHOLESTEROL INCREASED 5 0.0001
920 VOMITING 49 0.0001
921 LIVER FUNCTION TEST ABNORMAL 3 0.0001
922 ANXIETY 29 0.0001
923 RENAL INJURY 3 0.0001
924 IRRITABILITY 6 0.0001
925 LACRIMATION INCREASED 3 0.0001
926 CORONARY ARTERY DISEASE 3 0.0001
927 OSTEOPOROSIS 4 0.0001
928 FEELING ABNORMAL 23 0.0001
929 SKIN EXFOLIATION 8 0.0001
930 DEPRESSED MOOD 5 0.0001
931 HIP FRACTURE 3 0.0001
932 NIGHT SWEATS 3 0.0001
933 RHINORRHOEA 6 0.0001
934 RASH PRURITIC 5 0.0001
935 DEVICE LEAKAGE 4 0.0001
936 DEVICE DISLOCATION 4 0.0001
937 PRODUCT STORAGE ERROR 8 0.0001
938 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
939 FUNGAL INFECTION 3 0.0001
940 COLITIS ULCERATIVE 4 0.0001
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
942 APPLICATION SITE PRURITUS 2 0.0001
943 THROMBOSIS 7 0.0001
944 ADVERSE EVENT 8 0.0001
945 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
946 OCULAR HYPERAEMIA 4 0.0001
947 RASH ERYTHEMATOUS 4 0.0001
948 DEPRESSION 19 0.0001
949 PRODUCT DOSE OMISSION 5 0.0001
950 SUICIDAL IDEATION 7 0.0001
951 BREAST CANCER 7 0.0001
952 NEOPLASM MALIGNANT 5 0.0001
953 SWELLING 7 0.0001
954 PSORIATIC ARTHROPATHY 3 0.0001
955 BLINDNESS 3 0.0001
956 DRUG INTOLERANCE 7 0.0001
957 ANAPHYLACTIC REACTION 4 0.0001
958 BURNING SENSATION 5 0.0001
959 RHEUMATOID ARTHRITIS 8 0.0001
960 MENTAL DISORDER 3 0.0001
961 PAIN 42 0.0001
962 SINUSITIS 7 0.0001
963 ILLNESS 7 0.0001
964 NO ADVERSE EVENT 12 0.0001
965 RENAL CANCER 3 0.0001
966 MIGRAINE 6 0.0001
967 MULTIPLE SCLEROSIS 3 0.0001
968 INJECTION SITE BRUISING 5 0.0001
969 INJECTION SITE HAEMORRHAGE 5 0.0001
970 SWELLING FACE 4 0.0001
971 INFLUENZA LIKE ILLNESS 5 0.0001
972 THERAPY CESSATION 3 0.0001
973 ALOPECIA 11 0.0001
974 DEVICE ISSUE 5 0.0001
975 TREATMENT NONCOMPLIANCE 3 0.0001
976 MEDICATION ERROR 3 0.0001
977 CONVULSION 3 0.0001
978 INJECTION SITE SWELLING 4 0.0001
979 THERAPEUTIC RESPONSE DECREASED 3 0.0000
980 PSORIASIS 6 0.0000
981 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
982 PRODUCT QUALITY ISSUE 4 0.0000
983 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
984 EMOTIONAL DISTRESS 3 0.0000
985 INJECTION SITE ERYTHEMA 3 0.0000
986 INJECTION SITE PAIN 7 0.0000